K9 Immunity Capsules: Product Profile

K9 Immunity is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.

Oral capsules; current official page states 500 mg active blend per capsule. Intended species: Dogs.

Equal-proportion mushroom extracts: Cordyceps sinensis and Cordyceps militaris; Turkey Tail (Trametes versicolor); Shiitake (Lentinula edodes); Maitake (Grifola frondosa); Reishi (Ganoderma lucidum); Agaricus blazei. The manufacturer calls the blend Immune Assist and states a minimum 80% polysaccharides and beta-glucans.

The manufacturer markets K9 Immunity as a concentrated mushroom-extract capsule for immune support, recovery, and dogs facing cancer or chronic immune challenges. These are product-positioning statements; each asserted ingredient action is not automatically a demonstrated outcome of the finished product in canine cancer.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

The official page cites general research on mushroom-derived beta-glucans, not a controlled oncology trial of K9 Immunity capsules. The 2012 canine hemangiosarcoma PSP pilot used a different, standardized Coriolus product and cannot be transferred to this six-mushroom blend. No finished-product evidence for tumor response, progression-free interval, or survival was identified in the official materials reviewed.

A six-mushroom blend creates allergy, gastrointestinal, product-quality, immune-modulation, and interaction questions. Discuss autoimmune disease, immunosuppressive drugs, immunotherapy, anticoagulants, planned procedures, liver or kidney disease, pregnancy, and all other mushroom products. “Organic,” beta-glucan percentage, and GMP claims do not eliminate clinical uncertainty.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The official channel identifies K9 Immunity as a supplement and describes Hungarian certification language, but a current public competent-authority product record was not independently located in this review. It should not be presented as an approved anticancer medicine. Market availability and legal classification can differ by country.

European Union; Multiple European-language markets

Record the market-language version, lot, capsule strength, start date, and complete supplement list. Monitor appetite, vomiting, diarrhea, stool change, itching, swelling, energy, and body weight. The veterinarian should decide whether treatment-specific blood counts, chemistry, coagulation tests, or other monitoring require adjustment; do not infer tumor control from nonspecific vitality changes.